These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 23819554)
1. Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates. Barin J; Martins AF; Heineck BL; Barth AL; Zavascki AP Ann Clin Microbiol Antimicrob; 2013 Jul; 12():15. PubMed ID: 23819554 [TBL] [Abstract][Full Text] [Related]
2. Polymyxin B Heteroresistance and Adaptive Resistance in Multidrug- and Extremely Drug-Resistant Acinetobacter baumannii. Genteluci GL; de Souza PA; Gomes DBC; Sousa VS; de Souza MJ; Abib JRL; de Castro EAR; Rangel K; Villas Bôas MHS Curr Microbiol; 2020 Sep; 77(9):2300-2306. PubMed ID: 32494882 [TBL] [Abstract][Full Text] [Related]
3. Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran. Salehi B; Ghalavand Z; Mohammadzadeh M; Maleki DT; Kodori M; Kadkhoda H J Appl Microbiol; 2019 Nov; 127(5):1421-1429. PubMed ID: 31400237 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa. Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064 [TBL] [Abstract][Full Text] [Related]
5. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia. Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391 [TBL] [Abstract][Full Text] [Related]
6. Clinical and microbiological characteristics of OXA-23- and OXA-143-producing Acinetobacter baumannii in ICU patients at a teaching hospital, Brazil. Neves FC; Clemente WT; Lincopan N; Paião ID; Neves PR; Romanelli RM; Lima SS; Paiva LF; Mourão PH; Nobre-Junior VA Braz J Infect Dis; 2016; 20(6):556-563. PubMed ID: 27620658 [TBL] [Abstract][Full Text] [Related]
7. Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii. Lim TP; Ong RT; Hon PY; Hawkey J; Holt KE; Koh TH; Leong ML; Teo JQ; Tan TY; Ng MM; Hsu LY Antimicrob Agents Chemother; 2015 Dec; 59(12):7899-902. PubMed ID: 26438500 [TBL] [Abstract][Full Text] [Related]
8. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital. Thet KT; Lunha K; Srisrattakarn A; Lulitanond A; Tavichakorntrakool R; Kuwatjanakul W; Charoensri N; Chanawong A World J Microbiol Biotechnol; 2020 Jul; 36(7):102. PubMed ID: 32613355 [TBL] [Abstract][Full Text] [Related]
10. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey. Cakirlar FK; Ciftci IH; Gonullu N Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073 [TBL] [Abstract][Full Text] [Related]
11. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of OXA-type carbapenemases among Acinetobacter baumannii strains in a teaching hospital of Tehran. Zafari M; Feizabadi MM; Jafari S; Abdollahi A; Sabokbar A Acta Microbiol Immunol Hung; 2017 Dec; 64(4):385-394. PubMed ID: 28870091 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of different carbapenemase genes among carbapenem-resistant Wang TH; Leu YS; Wang NY; Liu CP; Yan TR Antimicrob Resist Infect Control; 2018; 7():123. PubMed ID: 30338061 [TBL] [Abstract][Full Text] [Related]
15. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152 [TBL] [Abstract][Full Text] [Related]
16. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Thomas VM; Brown RM; Ashcraft DS; Pankey GA Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230 [TBL] [Abstract][Full Text] [Related]
18. Distribution of Carbapenemases and Efflux Pump in Carbapenem-resistance Zhu LJ; Pan Y; Gao CY; Hou PF Ann Clin Lab Sci; 2020 Mar; 50(2):241-246. PubMed ID: 32366563 [No Abstract] [Full Text] [Related]
19. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
20. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples]. Keskin H; Tekeli A; Dolapci İ; Öcal D Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]